Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | TYR | P14679 | 2/20 | 0.63 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
| ▸ | MIF | P14174 | 1/20 | 0.63 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.63 |
| ▸ | ESR1 | P03372 | 9/20 | 0.60 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | AR | P10275 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.60 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.60 |
| ▸ | HTR6 | P50406 | 1/20 | 0.60 |
| ▸ | ESRRG | P62508 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10899440 | 0.90 | ALDH1A1 (0.57) | ALDH1A1HSD17B10ALOX15LMNATYR | |
| SCHEMBL18494 | 0.90 | ESR1 (0.64) | ALDH1A1HSD17B10ALOX15LMNATYR | |
| SCHEMBL123763 | 0.88 | ESR1 (0.59) | ALDH1A1HSD17B10ALOX15LMNATYR | |
| SCHEMBL29490659 | 0.88 | ESR1 (0.59) | ALDH1A1HSD17B10ALOX15LMNATYR | |
| SCHEMBL13609974 | 0.87 | ESR1 (0.65) | ALDH1A1HSD17B10ALOX15LMNATYR | |
| SCHEMBL686940 | 0.85 | ESR1 (0.62) | ALDH1A1HSD17B10ALOX15LMNATYR | |
| SCHEMBL9274292 | 0.85 | ESR1 (0.57) | ALDH1A1HSD17B10ALOX15LMNATYR | |
| SCHEMBL18635219 | 0.83 | ESR1 (0.69) | ALDH1A1HSD17B10ALOX15LMNATYR | |
| SCHEMBL18635220 | 0.83 | ESR1 (0.69) | ALDH1A1HSD17B10ALOX15LMNATYR | |
| SCHEMBL29372571 | 0.83 | ESR1 (0.60) | ALDH1A1HSD17B10ALOX15LMNATYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7534547-B2 | Optically active compound and photosensitive resin composition | OSAKA GAS COMPANY LIMITED (JP) | 2009-05-19 | — | — | US | disclosed |
| EP-1375463-A1 | OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | Kansai Research Institute, Inc. (JP) | 2004-01-02 | — | — | EP | disclosed |
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | KRI, INC. (JP) | 2003-11-13 | — | — | US | disclosed |
| EP-0341608-B1 | Resist composition, novel phenol compound and quinone diazide sulfonic acid ester of novel phenol compound | SUMITOMO CHEMICAL CO (JP) | 1996-09-11 | — | — | EP | disclosed |
| US-5290656-A | Positive photoresists | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-03-01 | — | — | US | disclosed |
| EP-0341608-A2 | Resist composition, novel phenol compound and quinone diazide sulfonic acid ester of novel phenol compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | ARCN1, RAD51, PAM | ALDH1A1 1552/4885HSD17B10 3699/4885ALOX15 336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.